Doximity vs Genedx Holdings
Doximity is the larger business, with $645m of revenue in fiscal 2026 against $428m for Genedx Holdings (1.5 times as much). Genedx Holdings grew faster (40.0% against 13.1%). Doximity kept more of each dollar of sales as profit: a net margin of 30.4% against -4.9%.
| Latest fiscal year | DoximityDOCS, 2026 | Genedx HoldingsWGS, 2025 |
|---|---|---|
| Revenue | $645m | $428m |
| Revenue growth | 13.1% | 40.0% |
| Net income | $196m | −$21.0m |
| Operating margin | 33.3% | — |
| Net margin | 30.4% | -4.9% |
| Return on equity | 19.3% | -7.6% |
| Free cash flow | $326m | $14.3m |
| Cash | $219m | $105m |
| Total debt | $0 | $54.5m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $432m | — |
| Employees | 880 | — |
| Market value | $5.85bn | $2.05bn |
| Price vs our value range | Within our value range | — |
| Moat score | 75 (Strong) | 16 (Weak) |
| Insider trades, 12 months | 0 buys, 21 sales | 34 buys, 105 sales |